An 18 year old man underwent liver transplantation due to an Abernethy malformation associated with multiple hepatocellular nodules including one which was a rapidly enlarging and was suspicious for malignant transformation. Analysis of the explanted liver showed a spectrum of multiple hepatocellular nodules ranging in appearance from focal nodular hyperplasia, hepatocellular adenoma and to a well differentiated hepatocellular neoplasm borderline for hepatocellular carcinoma. Mutational analysis revealed wildtype beta-catenin expression in the background liver and some nodules, whilst different variants were present in other lesions irrespective of their morphological appearance. No telomerase reverse transcriptase (TERT) promoter mutation was identified.
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Introduction
Abernethy malformation is the eponym applied to congenital extrahepatic portosystemic shunts, a rare anatomical abnormality in which the splanchnic venous flow bypasses the liver and drains directly into the systemic venous circulation. These malformations are commonly associated with other congenital abnormalities, such as polysplenia and congenital heart defects. They can also lead to complications including liver dysfunction, hepatic encephalopathy, and the development of hepatocellular nodules ranging from focal nodular hyperplasia to hepatocellular carcinoma [1, 2] The following case illustrates the occurrence of a spectrum of hepatocellular nodules in the context of an Abernethy malformation in an 18 year old man. Molecular analysis of these lesions revealed different beta-catenin mutations, an occurrence associated with malignant transformation of hepatocellular adenoma [3] . This case highlights the potential of such lesions to undergo malignant transformation and the importance of having a high index of suspicion during their follow-up.
Case Report
An 18 year old man was under our care, with multiple nodular hepatic lesions secondary to type 1 suggests several independent genetic events have occurred in this liver and that a risk of neoplastic progression for some of these lesions exists independent of their histological appearance. Table 1 describes the histological features, immunohistochemical profile and beta-catenin mutation status of the lesions observed. No mutation in the telomerase reverse transcriptase (TERT) promoter mutation was identified.
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Discussion
This case report is the first to demonstrate hepatocellular nodules with different beta-catenin mutations arising on a background of Abernethy malformation. Beta-catenin mutations are considered to be a risk factor for malignant transformation of HCA to HCC and it is therefore important to consider the possibility of such an event when monitoring people with Abernethy malformation. [3, 5] Abernethy malformations are congenital extrahepatic portosystemic shunts, which can be further classified using the anastomotic pattern between the portal and systemic veins. Type 1 exhibit complete absence of intrahepatic portal venous branches (end-to-side shunt) and can also be known as congenital absence of the portal vein. In type 2 there is preservation of intrahepatic venous supply but some portal flow is diverted through a side-to-side shunt into a systemic vein. [6] Patients with type 1 malformations have a female predominance (74%) and typically present early in life with associated congenital abnormalities which can be intra-abdominal or cardiac. [1, 6] Those with type 2 malformations are less likely to be affected by concomitant congenital defects and tend to present later in life with no sex preference. [1] The diagnosis of Abernethy malformation is often made when investigating infants and children for non-specific liver dysfunction and its sequelae, including hypoglycaemia, hyperammonaemia, hepatic encephalopathy, and portopulmonary hypertension. [1, 6] Imaging studies are diagnostic but liver biopsies may be used to supplement these modalities as histology may reveal changes to small portal vein branches or associated secondary parenchymal changes which would be indicative of an underlying anomaly of the vascular supply. [6] Approximately 50% of cases of Abernethy malformation are associated with hepatocellular nodules, ranging from FNH to HCC. A similar association has been described with other hepatic vascular disorders. [2, 6] A recent retrospective multicentre survey of hepatic vascular disorders with associated well differentiated hepatocellular nodules highlighted the need to consider these lesions as potentially different from the conventional ones arising in association with oral contraceptives use.
Such lesions are likely to have a different pathogenesis and natural history, and greater risk of malignant transformation. [2] Beta-catenin is an adherens junction protein involved in the Wnt signalling pathway, it is encoded by the 16 exon CTNNB1 gene at 3p22.1, (http://omim.org/entry/116806#0013). Disruption of betacatenin phosphorylation prevents degradation of the molecule causing constitutive activation of various TCF/LEF transcription factors and is associated with several malignancies (http://omim.org/entry/116806#0013). [3] HCAs with beta-catenin mutations are considered to be at risk of malignant transformation when compared to other subtypes and have been identified in HCCs. [3, 7] Indeed, the three beta-catenin variants found in these hepatocellular nodules, c.413T>C
(Ser45Pro), c.414C>T (Ser45Phe) and c.1004A>T (Lys335Ile) have previously been identified in a series of HCAs and HCCs. [7, 8] A C C E P T E D M A N U S C R I P T
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There are two particular aspects that need to be considered in this case. The first one is the occurrence of different types of beta-catenin mutation in the hepatocellular nodules but not in the background liver. Whether nodule formation related to the underlying vascular anomaly precedes the onset of beta-catenin mutation or the mutation precedes nodule development remains uncertain.
Systemic shunting of blood causes non-specific liver disturbance due to the unbalanced regional blood flow and arterialisation. It is thought that this leads to relative hepatic ischaemia and compensatory increase in hepatic arterial flow, in addition to altered exposure of hepatocytes to hormones and growth factors. [6] These factors could lead to abnormal liver development, function and regeneration and could provide a stimulus to tumour development. [6] The second aspect is that the beta-catenin mutations have occurred in nodules of different types including those resembling focal nodular hyperplasia histologically. Interestingly, transcriptome analysis of FNH has demonstrated activated hypophosphorylated beta-catenin protein accumulated in the absence of activating mutations. [9] The larger of the two lesions in this case report had an increase pattern of glutamine synthetase expression which deviated from the typical map-like one described by Bioulac-Sage et al. [10] and which could provide a clue to an underlying abnormality of the beta-catenin pathway. This supports the idea that hepatocellular lesions developing in the context of Abernethy malformation should be considered at risk of malignant progression independent of their size, histological and possibly radiological appearance, and that these patients should be followed up very closely. The multifocal nature of these lesions and genotypic heterogeneity indicate a field change, and emphasises the role of liver transplantation as a curative method in comparison with surgical resection targeted to more suspicious lesions.
Conclusion
This case report demonstrates that discrete beta-catenin mutations associated with malignant transformation can occur in hepatocellular nodules arising on a background of Abernethy malformation, independent of their size and histological appearance. The precise etiology is unclear, but may be common to other hepatic vascular disorders. It is therefore important to consider the possibility of malignant transformation of hepatocellular nodules when monitoring patients with Abernethy malformation, institute proper and close follow-up protocols and consider liver transplantation at a relatively early stage. Two DNA extractions on background liver were performed and one extraction each from the 6 tumours. *Tumour 6 was radiologically suspicious for transformation into hepatocellular carcinoma in part due to relatively rapid enlargement. Histologically, this lesion had some atypical features but fell short of an overt hepatocellular classification and is best classified as well differentiated hepatocellular neoplasm. The interval enlargement was explained by intralesional haemorrhage.
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